Inventor · disambiguated record
James Sutton
Also filed as: SUTTON JAMES · SUTTON JAMES C · SUTTON JAMES CLIFFORD · SUTTON JR JAMES C
47 granted patents·20 pending applications·433 citations·filing 1993–2024
98Inventor score
Files withBRISTOL MYERS SQUIBB CO15IDEAYA BIOSCIENCES INC13NOVARTIS AG11BARSANTI PAUL A4SUTTON JAMES4
Top patents by PatentIndex Score
67 records- 0196US6995183B2Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methodsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Feb 7, 2006·115 cites·7 claims
- 0295US7700620B2C-linked cyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditionsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Apr 20, 2010·21 cites·10 claims
- 0393US11084798B12-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitorsIDEAYA BIOSCIENCES INC·Filed 2021·Granted Aug 10, 2021·3 cites·26 claims
- 0492US11098051B2Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infectionsNOVARTIS AG·Filed 2017·Granted Aug 24, 2021·5 cites·19 claims
- 0592US10160764B2Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infectionsNOVARTIS AG·Filed 2017·Granted Dec 25, 2018·11 cites·29 claims
- 0691US11453677B2Tricyclic compounds useful to treat orthomyxovirus infectionsNOVARTIS AG·Filed 2020·Granted Sep 27, 2022·2 cites·14 claims
- 0790US11130759B12-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitorsIDEAYA BIOSCIENCES INC·Filed 2021·Granted Sep 28, 2021·2 cites·26 claims
- 0890US11046691B12-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitorsIDEAYA BIOSCIENCES INC·Filed 2021·Granted Jun 29, 2021·2 cites·28 claims
- 0990US7728008B2N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditionsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jun 1, 2010·17 cites·18 claims
- 1090US7553854B26-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signalingNOVARTIS VACCINES & DIAGNOSTIC·Filed 2007·Granted Jun 30, 2009·20 cites·78 claims
- 1189US8173689B26-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signalingSUTTON JAMES C·Filed 2009·Granted May 8, 2012·14 cites·6 claims
- 1289US8063063B2Immunopotentiating compoundsSUTTON JAMES·Filed 2007·Granted Nov 22, 2011·11 cites·10 claims
- 1387US10815250B2AhR modulatorsIDEAYA BIOSCIENCES INC·Filed 2019·Granted Oct 27, 2020·3 cites·24 claims
- 1487US8173657B2Imidazoquinoxaline compounds as immunomodulatorsSUTTON JAMES·Filed 2007·Granted May 8, 2012·5 cites·27 claims
- 1587US7645778B2Heteroaryl compounds as P2Y1 receptor inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jan 12, 2010·11 cites·16 claims
- 1687US6642252B2Acid derivatives useful as serine protease inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Nov 4, 2003·31 cites·24 claims
- 1786US8710048B26-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signalingSUTTON JAMES C·Filed 2012·Granted Apr 29, 2014·12 cites·28 claims
- 1886US6344450B1Lactam compounds and their use as inhibitors of serine proteases and methodBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Feb 5, 2002·31 cites·29 claims
- 1985US8957068B23-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDHCAFERRO THOMAS RAYMOND·Filed 2012·Granted Feb 17, 2015·13 cites·28 claims
- 2084US11407764B2AhR modulatorsIDEAYA BIOSCIENCES INC·Filed 2020·Granted Aug 9, 2022·1 cites·19 claims
- 2184US9434719B23-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDHCAFERRO THOMAS RAYMOND·Filed 2014·Granted Sep 6, 2016·7 cites·16 claims
- 2284US7820702B2Sulfonylpyrrolidine modulators of androgen receptor function and methodBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Oct 26, 2010·4 cites·14 claims
- 2384US2025011334A1Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infectionsNOVARTIS AG·Filed 2024·Application pending·0 cites
- 2482US7625923B2Bicyclic modulators of androgen receptor functionBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Dec 1, 2009·4 cites·14 claims
- 2581US10858366B2Tricyclic compounds useful to treat orthomyxovirus infectionsNOVARTIS AG·Filed 2017·Granted Dec 8, 2020·3 cites·20 claims
- 2681US8415381B2Heteroaryl compounds and their usesBARSANTI PAUL A·Filed 2010·Granted Apr 9, 2013·7 cites·12 claims
- 2780US9688672B23-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDHNOVARTIS AG·Filed 2016·Granted Jun 27, 2017·2 cites·14 claims
- 2879US8778951B2Heteroaryl compounds and their usesNOVARTIS AG·Filed 2013·Granted Jul 15, 2014·4 cites·8 claims
- 2979US7405234B2Bicyclic modulators of androgen receptor functionBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Jul 29, 2008·9 cites·22 claims
- 3078US8273772B2Heteroaryl compounds as P2Y1 receptor inhibitorsSUTTON JAMES C·Filed 2009·Granted Sep 25, 2012·3 cites·10 claims
- 3175US11584755B2Dihydrothieno[3,2-b]pyridine compoundsIDEAYA BIOSCIENCES INC·Filed 2018·Granted Feb 21, 2023·1 cites·18 claims
- 3274US12258354B2AhR modulatorsIDEAYA BIOSCIENCES INC·Filed 2022·Granted Mar 25, 2025·0 cites·14 claims
- 3373US11912715B2Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infectionsNOVARTIS AG·Filed 2021·Granted Feb 27, 2024·0 cites·22 claims
- 3472US6335324B1Beta lactam compounds and their use as inhibitors of tryptaseBRISTOL MYERS SQUIBB CO·Filed 1999·Granted Jan 1, 2002·37 cites·39 claims
- 3569US12503467B22-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitorsIDEAYA BIOSCIENCES INC·Filed 2019·Granted Dec 23, 2025·0 cites·17 claims
- 3669US8293769B2CSF-1R inhibitors, compositions, and methods of useNG SIMON C·Filed 2008·Granted Oct 23, 2012·2 cites·39 claims
- 3767US6713467B2Acid derivatives useful as serine protease inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Mar 30, 2004·3 cites·9 claims
- 3861US7772267B2Bicyclic modulators of androgen receptor functionBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Aug 10, 2010·0 cites·12 claims
- 3959US10537561B2CSF-1R inhibitors for treatment of brain tumorsNOVARTIS AG·Filed 2018·Granted Jan 21, 2020·0 cites·8 claims
- 4059US2014275083A13-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idhCAFERRO THOMAS RAYMOND·Filed 2014·Application pending·0 cites
- 4157US10112931B23-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDHNOVARTIS AG·Filed 2017·Granted Oct 30, 2018·0 cites·11 claims
- 4257US2024360082A1Substituted pyridone compounds useful to treat orthomyxovirus infectionsNOVARTIS AG·Filed 2022·Application pending·0 cites
- 4355US2013101622A1Imidazoquinoxaline compounds as immunomodulatorsSUTTON JAMES·Filed 2012·Application pending·0 cites
- 4454US7989640B2Sulfonylpyrrolidine modulators of androgen receptor function and methodBRISTOL MYERS SQUIBB CO·Filed 2010·Granted Aug 2, 2011·0 cites·5 claims
- 4554US2014288076A1Heteroaryl compounds and their usesBARSANTI PAUL A·Filed 2014·Application pending·0 cites
- 4653US7714002B2Carbocycle and heterocycle antagonists of P2Y1 receptor useful in the treatment of thrombotic conditionsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted May 11, 2010·0 cites·6 claims
- 4753US2022389003A14-substituted indole and indazole sulfonamido derivatives as parg inhibitorsIDEAYA BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 4852US2005228021A1Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methodsHAMANN LAWRENCE G·Filed 2005·Application pending·0 cites
- 4952US2005239839A1Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methodsHAMANN LAWRENCE G·Filed 2005·Application pending·0 cites
- 5049US2022340875A1Methods of culturing and/or expanding stem cells and/or lineage committed progenitor cells using amido compoundsIDEAYA BIOSCIENCES INC·Filed 2019·Application pending·0 cites
Showing the top 50 of 67 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →